A new formulation of Pfizer/BioNTech COVID-19 Vaccine "12 years and older, Ready to use (Original/Omicron BA.4-5 Grey Cap and Package, Multi-dose vial) was approved FOR BOOSTER DOSES ONLY on 12/09/22 with procedure II/143.
Additional website content relevant to this new formulation will be available soon
Pfizer-BioNTech COVID-19 Vaccine Original/Omicron BA.4-5 (15/15 micrograms)/ dose dispersion for injection, for 12 years and older, Ready to use (Grey Cap and Package, Multi-dose Vial)
This site is intended for Healthcare Professionals in Oman.
EUA Fact Sheet Updates
Please be aware that Pfizer-BioNTech COVID-19 Vaccine is now available in 6 formulations. For additional information on differences across age groups and formulations please see Vaccine Formulations Guide on the home page of this website.
Label Update: Effective 31 AUG 2022
Pfizer-BioNTech COVID-19 Vaccine, Bivalent, which is supplied in a multiple dose vial with an orange cap and a label with an orange border, should not be used in individuals 12 years of age and older.†
Updated shelf life for 12 years of age and older Dilute Before Use, Purple Cap formulation. Please see the Shelf Life & Storage page of this website for more information.
Important Safety Information has been updated. Please see the Safety & Efficacy page of this website for details.
*Monovalent refers to any authorised or approved COVID-19 vaccine that contains or encodes the spike protein of only the Original SARS-CoV-2.
†A different presentation of Pfizer-BioNTech COVID-19 Vaccine, Bivalent supplied in a single dose and multiple dose vials with gray caps and labels with gray borders is available for use in individuals 12 years of age and older.
Click below to view:
• EUA Fact Sheet for Vaccination Providers - 12 years of age and older Dilute Before Use, Purple Cap
• EUA Fact Sheet for Vaccination Providers - 12 years of age and older Do Not Dilute, Bivalent (Original and Omicron BA.4/BA.5), Gray Cap